Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats

Sung Jin Kim, Sang Ha Park, Song hyen Choi, Bo Hyun Moon, Kuem Ju Lee, Seung Woo Kang, Min-Soo Lee, Sang-Hyun Choi, Boe Gwun Chun, Kyung-Ho Shin

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Accumulating evidence suggests that dysregulation of corticotropin-releasing factor (CRF) may play a role in depression and that this dysregulation may be corrected by antidepressant drug treatment. Here, we examined whether chronic mild stress (CMS) alters CRF mRNA levels in stress-related brain areas including the bed nucleus of the stria terminalis (BNST) and the central nucleus of amygdala (CeA), and whether repeated tianeptine treatment can attenuate CMS-induced changes in CRF mRNA levels. Male rats were exposed to CMS for 19 days, and control animals were subjected to brief handling. Both groups were injected daily with tianeptine or saline. CMS significantly increased CRF mRNA levels in the dorsal BNST (dBNST), but not in other areas. Repeated tianeptine treatment prevented the CMS-induced increase in CRF mRNA levels in the dBNST, and reduced CRF mRNA levels in dBNST in non-stressed controls. Moreover, repeated tianeptine treatment significantly decreased CRF mRNA levels in the ventral BNST and CeA of non-stressed controls as well as CMS-exposed rats. These results show that CMS induces a rather selective increase of CRF mRNA in the dBNST. In addition, these results suggest that repeated tianeptine treatment diminishes the basal activity of CRF neurons and reduces their sensitivity to stress.

Original languageEnglish
Pages (from-to)824-833
Number of pages10
JournalNeuropharmacology
Volume50
Issue number7
DOIs
Publication statusPublished - 2006 Jun 1

Fingerprint

tianeptine
Corticotropin-Releasing Hormone
Messenger RNA
Septal Nuclei

Keywords

  • Amygdala
  • Anxiety
  • Bed nucleus of the stria terminalis
  • Corticotropin-releasing factor
  • Depression
  • Stress
  • Tianeptine

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. / Kim, Sung Jin; Park, Sang Ha; Choi, Song hyen; Moon, Bo Hyun; Lee, Kuem Ju; Kang, Seung Woo; Lee, Min-Soo; Choi, Sang-Hyun; Chun, Boe Gwun; Shin, Kyung-Ho.

In: Neuropharmacology, Vol. 50, No. 7, 01.06.2006, p. 824-833.

Research output: Contribution to journalArticle

Kim, Sung Jin ; Park, Sang Ha ; Choi, Song hyen ; Moon, Bo Hyun ; Lee, Kuem Ju ; Kang, Seung Woo ; Lee, Min-Soo ; Choi, Sang-Hyun ; Chun, Boe Gwun ; Shin, Kyung-Ho. / Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. In: Neuropharmacology. 2006 ; Vol. 50, No. 7. pp. 824-833.
@article{15fe74a819424fa3854ac82617733071,
title = "Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats",
abstract = "Accumulating evidence suggests that dysregulation of corticotropin-releasing factor (CRF) may play a role in depression and that this dysregulation may be corrected by antidepressant drug treatment. Here, we examined whether chronic mild stress (CMS) alters CRF mRNA levels in stress-related brain areas including the bed nucleus of the stria terminalis (BNST) and the central nucleus of amygdala (CeA), and whether repeated tianeptine treatment can attenuate CMS-induced changes in CRF mRNA levels. Male rats were exposed to CMS for 19 days, and control animals were subjected to brief handling. Both groups were injected daily with tianeptine or saline. CMS significantly increased CRF mRNA levels in the dorsal BNST (dBNST), but not in other areas. Repeated tianeptine treatment prevented the CMS-induced increase in CRF mRNA levels in the dBNST, and reduced CRF mRNA levels in dBNST in non-stressed controls. Moreover, repeated tianeptine treatment significantly decreased CRF mRNA levels in the ventral BNST and CeA of non-stressed controls as well as CMS-exposed rats. These results show that CMS induces a rather selective increase of CRF mRNA in the dBNST. In addition, these results suggest that repeated tianeptine treatment diminishes the basal activity of CRF neurons and reduces their sensitivity to stress.",
keywords = "Amygdala, Anxiety, Bed nucleus of the stria terminalis, Corticotropin-releasing factor, Depression, Stress, Tianeptine",
author = "Kim, {Sung Jin} and Park, {Sang Ha} and Choi, {Song hyen} and Moon, {Bo Hyun} and Lee, {Kuem Ju} and Kang, {Seung Woo} and Min-Soo Lee and Sang-Hyun Choi and Chun, {Boe Gwun} and Kyung-Ho Shin",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.neuropharm.2005.12.003",
language = "English",
volume = "50",
pages = "824--833",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats

AU - Kim, Sung Jin

AU - Park, Sang Ha

AU - Choi, Song hyen

AU - Moon, Bo Hyun

AU - Lee, Kuem Ju

AU - Kang, Seung Woo

AU - Lee, Min-Soo

AU - Choi, Sang-Hyun

AU - Chun, Boe Gwun

AU - Shin, Kyung-Ho

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Accumulating evidence suggests that dysregulation of corticotropin-releasing factor (CRF) may play a role in depression and that this dysregulation may be corrected by antidepressant drug treatment. Here, we examined whether chronic mild stress (CMS) alters CRF mRNA levels in stress-related brain areas including the bed nucleus of the stria terminalis (BNST) and the central nucleus of amygdala (CeA), and whether repeated tianeptine treatment can attenuate CMS-induced changes in CRF mRNA levels. Male rats were exposed to CMS for 19 days, and control animals were subjected to brief handling. Both groups were injected daily with tianeptine or saline. CMS significantly increased CRF mRNA levels in the dorsal BNST (dBNST), but not in other areas. Repeated tianeptine treatment prevented the CMS-induced increase in CRF mRNA levels in the dBNST, and reduced CRF mRNA levels in dBNST in non-stressed controls. Moreover, repeated tianeptine treatment significantly decreased CRF mRNA levels in the ventral BNST and CeA of non-stressed controls as well as CMS-exposed rats. These results show that CMS induces a rather selective increase of CRF mRNA in the dBNST. In addition, these results suggest that repeated tianeptine treatment diminishes the basal activity of CRF neurons and reduces their sensitivity to stress.

AB - Accumulating evidence suggests that dysregulation of corticotropin-releasing factor (CRF) may play a role in depression and that this dysregulation may be corrected by antidepressant drug treatment. Here, we examined whether chronic mild stress (CMS) alters CRF mRNA levels in stress-related brain areas including the bed nucleus of the stria terminalis (BNST) and the central nucleus of amygdala (CeA), and whether repeated tianeptine treatment can attenuate CMS-induced changes in CRF mRNA levels. Male rats were exposed to CMS for 19 days, and control animals were subjected to brief handling. Both groups were injected daily with tianeptine or saline. CMS significantly increased CRF mRNA levels in the dorsal BNST (dBNST), but not in other areas. Repeated tianeptine treatment prevented the CMS-induced increase in CRF mRNA levels in the dBNST, and reduced CRF mRNA levels in dBNST in non-stressed controls. Moreover, repeated tianeptine treatment significantly decreased CRF mRNA levels in the ventral BNST and CeA of non-stressed controls as well as CMS-exposed rats. These results show that CMS induces a rather selective increase of CRF mRNA in the dBNST. In addition, these results suggest that repeated tianeptine treatment diminishes the basal activity of CRF neurons and reduces their sensitivity to stress.

KW - Amygdala

KW - Anxiety

KW - Bed nucleus of the stria terminalis

KW - Corticotropin-releasing factor

KW - Depression

KW - Stress

KW - Tianeptine

UR - http://www.scopus.com/inward/record.url?scp=33646679190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646679190&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2005.12.003

DO - 10.1016/j.neuropharm.2005.12.003

M3 - Article

VL - 50

SP - 824

EP - 833

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 7

ER -